Open Access

Erratum to: Patients’, clinicians’ and the research communities’ priorities for treatment research: there is an important mismatch

  • Sally Crowe1Email author,
  • Mark Fenton2,
  • Matthew Hall3,
  • Katherine Cowan4 and
  • Iain Chalmers5
Research Involvement and Engagement20151:14

DOI: 10.1186/s40900-015-0014-7

Received: 12 December 2015

Accepted: 12 December 2015

Published: 23 December 2015

The original article was published in Research Involvement and Engagement 2015 1:2

The authors wish to apologize to readers for an incorrect element in Table 1 and Figure 1 in the original article [1]. The correct files have been included in this erratum. We also wish to thank Sara Heesterbeek for alerting us to our error.
Table 1

Interventions mentioned in research priorities identified by James Lind Alliance Priority Setting Partnerships, and among registered trials, 2003-2012

Type of intervention

JLA patient-clinician Priority Setting Partnerships

Registered non-commercial trials

Registered commercial trials

Percentages (numbers) of interventions out of a total of 126 interventions mentioned

Percentage (numbers) of interventions out of a total of 1069 interventions mentioned

Percentage (numbers) of interventions out of a total of 798 interventions mentioned

Drugs, vaccines and biologicals

18 (23)

37 (397)

86 (689)

Radiotherapy, surgery and perioperative, devices, and diagnostic

23 (29)

31 (332)

11 (89)

Education and training, service delivery, psychological therapy, physical therapies, exercise, complementary therapies, social care, mixed or complex, diet, other

59 (74)

32 (340)

3 (20)

https://static-content.springer.com/image/art%3A10.1186%2Fs40900-015-0014-7/MediaObjects/40900_2015_14_Fig1_HTML.gif
Fig. 1

Interventions mentioned in commercial trials, non-commercial trials and research priorities identified by James Lind Alliance Priority Setting Partnerships, 2003-2012

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Crowe Associates Ltd.
(2)
UK DUETs, NHS Evidence, National Institute of Health and Social Care Excellence
(3)
Institute for Evolutionary Biology, University of Edinburgh
(4)
Katherine Cowan Consulting Ltd.
(5)
James Lind Initiative, Summertown Pavilion

Reference

  1. Crowe S, Fenton M, Hall M, Cowan K, Chalmers I. Patients’, clinicians’ and the research communities’ priorities for treatment research: there is an important mismatch. Research Involvement and Engagement. 2015;1:2.View ArticleGoogle Scholar

Copyright

© Crowe et al. 2016

Advertisement